Mode
Text Size
Log in / Sign up
N/A Completed N=106 Randomized Treatment

Wearable Technology to Reduce Risk of DVT and Increase Patient Compliance

Orthopedic Disorder
Source: ClinicalTrials.gov NCT04995601 ↗
Enrolled (actual)
106
Serious AEs
0.0%
Results posted
Sep 2024
Primary outcomePrimary: Compliance to Prescribed Use — 67.7; 83.3 percentage of prescribed use/24hr

Summary

The primary purpose of this study is to conduct a multi-site clinical trial of the Recovery Force Movement and Compressions (RF MAC) System. The study is a randomized comparative study of DVT prophylaxis using either standard IPC (Group 1) or the RF MAC system (Group 2) in 300 patients after TJR surgery at two study sites: Tufts Medical Center (Boston, Massachusetts) and Eskenazi Hospital (Indianapolis, Indiana). This study is funded by a Phase II SBIR awarded to Recovery Force from the National Institutes of Health, National Heart, Lung and Blood Institute (R44-HL132624-02).

Outcome Measures

OutcomeResultp-value
PRIMARY
Compliance to Prescribed Use
67.7; 83.3
PRIMARY
Patient-reported Comfort
3.1; 3.5
PRIMARY
Patient-reported Ease-of-use
2.6; 2.3

Eligibility Criteria

Inclusion Criteria

  • adult patients (age 40-85)
  • first elective total hip replacement (THR) or first or second (opposite knee) elective total knee replacement (TKA
  • speak English
  • expected to have a hospital stay of two days or less
  • discharge to home from hospital (not a rehabilitation facility)
  • must be able to perform self-care
  • BMI between 18 and 39
  • calf circumference between 11 and 24.5 inches

Exclusion Criteria

  • partial joint replacement, TJR revisions, emergency surgeries
  • calf deformities that would not allow proper fit for external compression device
  • non-ambulatory
  • clinically malnourished or frail/deconditioned
  • vulnerable patients (pregnant women, prisoners, homeless and cognitively impaired)
  • do not speak English
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04995601). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search